Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-432-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19-06-2104 to 20-08-2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Principles of method if other than guideline:
- The critieria for a positive outcome differ from the standard Test guideline- the MB model examines the tissue viability (EC50) at three set exposure timepoints 1,4 and 24 hours, whereas the validated OECD method has an exposure time of 60 minutes and a post exposure period of incubation period of 42 hours before the tissue viability is measured for Mattek EpiDerm. The MB protocol doses 100 mg/tissue whereas the OECD guideline for Epiderm is only 25 mg/tissue plus 25µL dulbeccos PBS for tissue wetting (39mg/cm2)
- GLP compliance:
- yes
Test material
- Reference substance name:
- (2S,3S)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid — methyl {(4S)-8-fluoro-2-[4-(3methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4yl}acetate — ethyl acetate (1:1:1)
- EC Number:
- 947-432-4
- Cas Number:
- 2241754-97-0
- Molecular formula:
- C30H30F4N4O4.C20H18O8.C4H8O2
- IUPAC Name:
- (2S,3S)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid — methyl {(4S)-8-fluoro-2-[4-(3methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4yl}acetate — ethyl acetate (1:1:1)
- Test material form:
- solid
- Details on test material:
- lot L--005457795-001 G001
Constituent 1
- Specific details on test material used for the study:
- L-005457795-001 G001 Off-white powder Used as received analysis >90% w/w 6-9% ethyl acetate
In vitro test system
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: Not specified
- Source strain:
- not specified
- Justification for test system used:
- To provide an estimate of dermal irritation potential using an alternative to the Draize methodology. The
MatTek EpiDerm ™ MTT Viability Assay has been demonstrated to be a quantitative method for
assessing potential skin hazards. - Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: Mattek Epiderm
- Tissue batch number(s): Lot 20521 Kit F
- Delivery date: 24 Jun 2014
- Date of initiation of testing: 24 Jun 2014
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37 C
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1mg/ml in DMEM
- Incubation time: 3 hrs extraction time overnight
- Spectrophotometer:
IJQuant Plate Reader, Bio-Tek Instruments,Winooski, VT
- Wavelength:
540nm subtracting absorbance at 690nm
NUMBER OF REPLICATE TISSUES:
2
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
For each test article, 100 mg of the test articie were mixed with 1 ml of MTT solution (1 mg/ml Methyl
thiazole tetrazolium diluted in Dulbecco's Modified Eagle's Medium (DMEM)). A Negative Control, 100 IJI
of tissue culture water, was tested concurrently. The soiutions were incubated at room temperature in the
dark for 60 minutes. After incubation, the solutions were Visually inspected for purple coloration, which
indicates that the test articie reduced MTT. Since tissue viability is based on MTT reduction, direct
reduction by a test article can exaggerate viability, making a test article seem less irritating than it really is.
Neither of the test articles was found to have reduced MTT and the assay continued as per the protocol.
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION:
single
PREDICTION MODEL / DECISION CRITERIA (choose relevant statement)
- Justification for the selection of the cut-off point(s) if different than recommended in TG 431 and 439:
As per MatTek, as a general guideline, the following groups can be used to assign expected in vivo
irritancy responses based on the ET50 resuits obtained using the EpiDerm™ MIT Viability Assay:
Expected In vivo Irritancy Example ET50 (hrs)
Severe, Probable Corrosive Concentrated Nitric acid < 0.5
Moderate 1% Sodium Dodecyl Sulfate 0.5 - 4
Moderate to Mild 1% Triton'" X-100 4 -12
Very Mild Baby shampoo 12 - 24
Non-irritating 10% Tween'" 20 > 24 - Control samples:
- yes, concurrent no treatment
- yes, concurrent positive control
- Amount/concentration applied:
- 100 mg/tissue
- Duration of treatment / exposure:
- 1, 4 and 24 hours
- Duration of post-treatment incubation (if applicable):
- none
- Number of replicates:
- duplicates
Results and discussion
In vitro
Results
- Irritation / corrosion parameter:
- other: ET50 (hrs)
- Run / experiment:
- L-005457795-001 G001
- Value:
- > 24
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
Any other information on results incl. tables
Test Article L-005457795-001 G001 results
| ||||||
dose 100mg | test concentration : neat |
|
|
| ||
time (Hrs) | OD1 | OD2 | OD mean | SD | viability % | error % |
1 | 1.862 | 1.753 | 1.808 | 0.077 | 97.6 | 4.2 |
4.0 | 2.179 | 2.124 | 2.152 | 0.039 | 116.1 | 2.1 |
24.0 | 1.745 | 2.001 | 1.873 | 0.181 | 101.1 | 9.8 |
neg control | 1.903 | 1.802 | 1.853 | 0.071 | 100.0 | 3.9 |
ET50 (hrs) >24 | Irritancy classification Non-irritating |
|
|
|
Positve control 1% Triton X-100
dose 100µl |
concentration: neat
|
|
|
| ||
time (Hrs) | OD1 | OD2 | OD mean | SD | Viability % | error % |
4 | 1.824 | 1.628 | 1.726 | 0.139 | 93.2 | 7.5 |
9 | 0.154 | 0.142 | 0.148 | 0.008 | 8.0 | 0.5 |
neg control | 1.903 | 1.802 | 1.853 | 0.071 | 100.0 | 3.6 |
ET50 (hrs): 6.0 | Irritancy classificaiton : within range (4.8 -8.7) |
Applicant's summary and conclusion
- Interpretation of results:
- other: non guideline critieria- likely non-irritant
- Conclusions:
- The test article was not irritant according to the criteria set out by the Testing laboratory- the assay was not conducted in accordance with the OECD test guideline or EU test method, therefore no conclusion can be made regarding irritancy on the basis of the validated acceptance critieria. Expert judgement would suggest that the substance is non-irritant based on the tissue viabilities observed.
- Executive summary:
OBJECTIVE: To provide an estimate of dermal irritation potential using an alternative to the Draize methodoiogy. The MatTek EpiDerm ™ MIT Viability Assay has been demonstrated to be a quantitative method for assessing potential skin hazards.
METHOD SYNOPSIS: MatTek EpiDerm™ tissue samples were treated in duplicate with the test article and Positive Control for various exposure times listed below. Negative Controls (undosed tissues) were tested at 4 hours only. Following treatment, the viability of the tissues was determined using Methyl thiazole tetrazolium (MTT) uptake and reduction. The absorbance of each sample was measured at 540nm using a reference wavelength of 690 nm. The viability was then expressed as a percent of Control values. The mean percent viability for each time point was used to calculate an ET50, which represents the time at which the EpiDerm™ tissue viability was reduced 50% compared to Negative Control tissues.
The ET 50 scores were converted to an irritancy classification.
SUMMARY/CONCLUSION:
Test and Control Article Identity Exposure Times (hrs) ET50 (hrs) Irritancy Classification
L-005457795-001 G001 1,4,24 >24.0 Non-Irritating
1% Triton® X-100 (Positive Control) 4,9 6.0 Within Range (4.8 - 8.7)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.